
Epidemiology and susceptibility profile to classic antifungals and over-the-counter products of Malassezia clinical isolates from a Portuguese University Hospital: a prospective study
Author(s) -
Ana Pedrosa,
Cármen Lisboa,
Isabel FariaRamos,
Raquel M. Silva,
Elisabete Ricardo,
Rita TeixeiraSantos,
Isabel M. Miranda,
Acácio Gonçalves Rodrigues
Publication year - 2019
Publication title -
journal of medical microbiology/journal of medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.91
H-Index - 117
eISSN - 1473-5644
pISSN - 0022-2615
DOI - 10.1099/jmm.0.000966
Subject(s) - malassezia , pityriasis , terbinafine , seborrheic dermatitis , fluconazole , dermatology , broth microdilution , medicine , epidemiology , microbiology and biotechnology , biology , antifungal , itraconazole , minimum inhibitory concentration , antibiotics
Clinical epidemiological data about the distinct Malassezia species remain scarce. The recurrence of Malassezia-related skin diseases, despite long-term use of antifungals, raises concern about the hypothetical emergence of antifungal resistance. We aimed to assess the distribution of Malassezia species among patients from a University Hospital with pityriasis versicolor, seborrheic dermatitis and healthy volunteers, and to evaluate the susceptibility profile to classic antifungals and over-the-counter compounds, searching for clinical associations.